Oklahoma SB426 designates chloroquine, hydroxychloroquine, and ivermectin as over-the-counter drugs, prohibiting pharmacists from requiring.
Oklahoma SB426 amends the Oklahoma Statutes to classify chloroquine, hydroxychloroquine, and ivermectin as over-the-counter drugs. This means pharmacists and pharmacies cannot require a prescription for these drugs. The State Board of Pharmacy is mandated to revoke the license of any pharmacist or pharmacy found in violation of this provision and impose a fine of One Hundred Thousand Dollars ($100,000.00) per occurrence. The act will take effect on November 1, 2025.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.